|
2020 Journal Article The AGITG GAP study: a phase II study of perioperative gemcitabine and nab-paclitaxel for resectable pancreas cancerBarbour, Andrew P., Samra, Jaswinder S., Haghighi, Koroush S., Donoghoe, Mark W., Burge, Matthew, Harris, Marion T., Chua, Yu Jo, Mitchell, Jenna, O’Rourke, Nick, Chan, Howard, Gebski, Val J., Gananadha, Sivakumar, Croagh, Daniel G., Kench, James G., Goldstein, David, Barbour, A., Goldstein, D., Samra, J. S., Harris, M., Chua, Y. J., O’Rourke, N., Yip, S., Gebski, V., Simes, J., Hicks, R., Coates, A., Gurney, H., Do, V., Marschner, I. ... Jones, R. (2020). The AGITG GAP study: a phase II study of perioperative gemcitabine and nab-paclitaxel for resectable pancreas cancer. Annals of Surgical Oncology, 27 (7), 2506-2515. doi: 10.1245/s10434-020-08205-2 |
|
2020 Journal Article Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinomaKryza, Thomas, Khan, Tashbib, Puttick, Simon, Li, Chao, Sokolowski, Kamil A., Tse, Brian W.C., Cuda, Tahleesa, Lyons, Nicholas, Gough, Madeline, Yin, Julia, Parkin, Ashleigh, Deryugina, Elena I., Quigley, James P., Law, Ruby H.P., Whisstock, James C., Riddell, Andrew D., Barbour, Andrew P., Wyld, David K., Thomas, Paul A., Rose, Stephen, Snell, Cameron E., Pajic, Marina, He, Yaowu and Hooper, John D. (2020). Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma. Theranostics, 10 (9), 4116-4133. doi: 10.7150/thno.43589 |
|
2019 Journal Article Baseline neutrophil–lymphocyte ratio holds no prognostic value for esophageal and junctional adenocarcinoma in patients treated with neoadjuvant chemotherapyvan Hootegem, S. J. M., Smithers, B. M., Gotley, D. C., Brosda, S., Thomson, I. G., Thomas, J. M., Gartside, M. and Barbour, A. P. (2019). Baseline neutrophil–lymphocyte ratio holds no prognostic value for esophageal and junctional adenocarcinoma in patients treated with neoadjuvant chemotherapy. Diseases of the Esophagus, 33 (6) doz082. doi: 10.1093/dote/doz082 |
|
2019 Journal Article The impact of signet ring cell differentiation on outcome in patients with esophageal and gastroesophageal junction adenocarcinomavan Hootegem, Sander J. M., Smithers, B. Mark, Gotley, David C., Brosda, Sandra, Thomson, Iain G., Thomas, Janine M., Gartside, Michael, van Lanschot, Jan J. B., Lagarde, Sjoerd M., Wijnhoven, Bas P. L. and Barbour, Andrew P. (2019). The impact of signet ring cell differentiation on outcome in patients with esophageal and gastroesophageal junction adenocarcinoma. Annals of Surgical Oncology, 26 (8), 2375-2384. doi: 10.1245/s10434-019-07322-x |
|
2019 Journal Article CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecanVennin, Claire, Melenec, Pauline, Rouet, Romain, Nobis, Max, Cazet, Aurelie S., Murphy, Kendelle J., Herrmann, David, Reed, Daniel A., Lucas, Morghan C., Warren, Sean C., Elgundi, Zehra, Pinese, Mark, Kalna, Gabriella, Roden, Daniel, Samuel, Monisha, Zaratzian, Anaiis, Grey, Shane T., Da Silva, Andrew, Leung, Wilfred, Mathivanan, Suresh, Wang, Yingxiao, Braithwaite, Anthony W., Christ, Daniel, Benda, Ales, Parkin, Ashleigh, Phillips, Phoebe A., Whitelock, John M., Gill, Anthony J., Sansom, Owen J. ... Australian Pancreatic Genome Initiative (APGI) (2019). CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan. Nature Communications, 10 (1) 3637. doi: 10.1038/s41467-019-10968-6 |
|
2019 Journal Article To be or not to be: Non-invasive screening for Barrett’s esophagus, dysplasia and adenocarcinomaShah, Alok K., Joshi, Virendra, Hartel, Gunter, Barbour, Andrew P. and Hill, Michelle M. (2019). To be or not to be: Non-invasive screening for Barrett’s esophagus, dysplasia and adenocarcinoma. Translational Gastroenterology and Hepatology, 4 (May) 31, 31-31. doi: 10.21037/tgh.2019.04.08 |
|
2019 Journal Article Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: an Australian multi-center studyKroon, Hidde M., Coventry, Brendon J., Henderson, Michael A., Barbour, Andrew, Serpell, Jonathan, Smithers, B. Mark and Thompson, John F. (2019). Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: an Australian multi-center study. European Journal of Surgical Oncology, 45 (5), 832-837. doi: 10.1016/j.ejso.2019.02.026 |
|
2019 Journal Article Complex structural rearrangements are present in high-grade dysplastic Barrett's oesophagus samplesNewell, Felicity, Patel, Kalpana, Gartside, Michael, Krause, Lutz, Brosda, Sandra, Aoude, Lauren G., Loffler, Kelly A., Bonazzi, Vanessa F., Patch, Ann-Marie, Kazakoff, Stephen H., Holmes, Oliver, Xu, Qinying, Wood, Scott, Leonard, Conrad, Lampe, Guy, Lord, Reginald V., Whiteman, David C., Pearson, John V., Nones, Katia, Waddell, Nicola and Barbour, Andrew P. (2019). Complex structural rearrangements are present in high-grade dysplastic Barrett's oesophagus samples. BMC Medical Genomics, 12 (1) 31, 31. doi: 10.1186/s12920-019-0476-9 |
|
2019 Journal Article Patients with in-transit melanoma metastases have comparable survival outcomes following isolated limb infusion or intralesional PV-10-A propensity score matched, single center studyRead, Tavis, Fayers, Warren, Thomas, Janine, Wagels, Michael, Barbour, Andrew and Smithers, B. Mark (2019). Patients with in-transit melanoma metastases have comparable survival outcomes following isolated limb infusion or intralesional PV-10-A propensity score matched, single center study. Journal of Surgical Oncology, 119 (6), 717-727. doi: 10.1002/jso.25373 |
|
2018 Journal Article Evaluation of serum glycoprotein biomarker candidates for detection of esophageal adenocarcinoma and surveillance of Barrett’s esophagusShah, Alok K., Hartel, Gunter, Brown, Ian, Winterford, Clay, Na, Renhua, Lê Cao, Kim-Anh, Spicer, Bradley A., Dunstone, Michelle A., Phillips, Wayne A, Lord, Reginald V., Barbour, Andrew P., Watson, David I., Joshi, Virendra, Whiteman, David C. and Hill, Michelle M. (2018). Evaluation of serum glycoprotein biomarker candidates for detection of esophageal adenocarcinoma and surveillance of Barrett’s esophagus. Molecular and Cellular Proteomics, 17 (12), 2324-2334. doi: 10.1074/mcp.ra118.000734 |
|
2018 Journal Article Patterns of failure following dose-escalated chemoradiotherapy for fluorodeoxyglucose positron emission tomography staged squamous cell carcinoma of the oesophagusEffeney, R., Shaw, T., Burmeister, B. H., Burmeister, E., Harvey, J., Mai, G. T., Thomas, J., Barbour, A. P., Smithers, B. M. and Pryor, D. I. (2018). Patterns of failure following dose-escalated chemoradiotherapy for fluorodeoxyglucose positron emission tomography staged squamous cell carcinoma of the oesophagus. Clinical Oncology, 30 (10), 642-649. doi: 10.1016/j.clon.2018.06.011 |
|
2018 Journal Article Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagusVisser, Els, Edholm, David, Smithers, B. Mark, Thomson, Iain G., Burmeister, Bryan H., Walpole, Euan T., Gotley, David C., Joubert, Warren L., Atkinson, Victoria, Mai, Tao, Thomas, Janine M. and Barbour, Andrew P. (2018). Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagus. Journal of Surgical Oncology, 117 (8), 1687-1696. doi: 10.1002/jso.25089 |
|
2018 Journal Article Neoadjuvant therapy reduces cardiopulmunary function in patients undegoing oesophagectomyThomson, Iain G., Wallen, Matthew P., Hall, Adrian, Ferris, Rebekah, Gotley, David C., Barbour, Andrew P., Lee, Andrew, Thomas, Janine and Smithers, Bernard M. (2018). Neoadjuvant therapy reduces cardiopulmunary function in patients undegoing oesophagectomy. International Journal of Surgery, 53, 86-92. doi: 10.1016/j.ijsu.2018.03.030 |
|
2018 Journal Article Intralesional PV-10 for the treatment of in-transit melanoma metastases-Results of a prospective, non-randomized, single center studyRead, Tavis A., Smith, Aaron, Thomas, Janine, David, Michael, Foote, Matthew, Wagels, Michael, Barbour, Andrew and Smithers, B. Mark (2018). Intralesional PV-10 for the treatment of in-transit melanoma metastases-Results of a prospective, non-randomized, single center study. Journal of Surgical Oncology, 117 (4), 579-587. doi: 10.1002/jso.24921 |
|
2018 Journal Article Breaking bad conduits: 'resleeving' the intrathoracic gastric conduit post oesophagectomyEvennett, Nicholas J. and Barbour, Andrew P. (2018). Breaking bad conduits: 'resleeving' the intrathoracic gastric conduit post oesophagectomy. ANZ Journal of Surgery, 88 (3), E222-E223. doi: 10.1111/ans.13337 |
|
2017 Journal Article Genomic Perturbations Reveal Distinct Regulatory Networks in Intrahepatic CholangiocarcinomaNepal, Chirag, O'Rourke, Colm J., Oliveira, Douglas Vnp, Taranta, Andrzej, Shema, Steven, Gautam, Prson, Calderaro, Julien, Barbour, Andrew, Raggi, Chiara, Wennerberg, Krister, Wang, Xin W., Lautem, Anja, Roberts, Lewis R. and Andersen, Jesper B. (2017). Genomic Perturbations Reveal Distinct Regulatory Networks in Intrahepatic Cholangiocarcinoma. Hepatology (Baltimore, Md.), 68 (3), 949-963. doi: 10.1002/hep.29764 |
|
2017 Journal Article Identification of unique neoantigen qualities in long-term survivors of pancreatic cancerBalachandran, Vinod P., Łuksza, Marta, Zhao, Julia N., Makarov, Vladimir, Moral, John Alec, Remark, Romain, Herbst, Brian, Askan, Gokce, Bhanot, Umesh, Senbabaoglu, Yasin, Wells, Daniel K., Cary, Charles Ian Ormsby, Grbovic-Huezo, Olivera, Attiyeh, Marc, Medina, Benjamin, Zhang, Jennifer, Loo, Jennifer, Saglimbeni, Joseph, Abu-Akeel, Mohsen, Zappasodi, Roberta, Riaz, Nadeem, Smoragiewicz, Martin, Larkin Kelley, Z., Basturk, Olca, Gönen, Mithat, Levine, Arnold J., Allen, Peter J., Fearon, Douglas T., Merad, Miriam ... Bassi, Claudio (2017). Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. Nature, 551 (7681), 512-516. doi: 10.1038/nature24462 |
|
2017 Journal Article Safety and Efficacy of Isolated Limb Infusion Chemotherapy for Advanced Locoregional Melanoma in Elderly Patients: An Australian Multicenter StudyKroon, Hidde M., Coventry, Brendon J., Giles, Mitchell H., Henderson, Michael A., Speakman, David, Wall, Mark, Barbour, Andrew, Serpell, Jonathan, Paddle, Paul, Smithers, Bernard M. and Thompson, John F. (2017). Safety and Efficacy of Isolated Limb Infusion Chemotherapy for Advanced Locoregional Melanoma in Elderly Patients: An Australian Multicenter Study. Annals of Surgical Oncology, 24 (11), 3245-3251. doi: 10.1245/s10434-017-6046-5 |
|
2017 Journal Article When is a sentinel node biopsy indicated for patients with primary melanoma? An update of the 'Australian guidelines for the management of cutaneous melanoma'Gyorki, David E., Barbour, Andrew, Hanikeri, Mark, Mar, Victoria, Sandhu, Shahneen and Thompson, John F. (2017). When is a sentinel node biopsy indicated for patients with primary melanoma? An update of the 'Australian guidelines for the management of cutaneous melanoma'. Australasian Journal of Dermatology, 58 (4), 274-277. doi: 10.1111/ajd.12662 |
|
2017 Journal Article Primary cutaneous melanoma of the scalp: Patterns of recurrenceSparks, David S., Read, Tavis, Lonne, Michael, Barbour, Andrew P., Wagels, Michael, Bayley, Gerard J. and Smithers, B. Mark (2017). Primary cutaneous melanoma of the scalp: Patterns of recurrence. Journal of Surgical Oncology, 115 (4), 449-454. doi: 10.1002/jso.24535 |
